SuzanneRhodesSharptonMDMAS

PubMed

• Reply: Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC.
  Suzanne Sharpton, Rohit Loomba> ;Hepatology. 2024 Mar 11
• 1 citations
  Editorial: Assessing advanced fibrosis in metabolic-associated steatotic liver disease-The MAFLD fibrosis score.
  Suzanne Sharpton> ;Alimentary Pharmacology & Therapeutics. 2023 Dec 1
• 10 citations
  Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD.
  Nobuharu Tamaki, Kento Imajo, Suzanne R Sharpton, Jinho Jung, Nancy Sutter, Nobuyoshi Kawamura, Masato Yoneda, Mark A Valasek, Cynthia Behling, Claude B Sirlin, Masayu...> ;Clinical Gastroenterology and Hepatology. 2023 Feb 1
• 7 citations
  Prevalence and factors associated with liver fibrosis among first-degree relatives of Mexican Americans with hepatocellular carcinoma.
  Suzanne Sharpton, Kuangda Shan, Ricki Bettencourt, Miryoung Lee, Joseph B McCormick, Susan P Fisher-Hoch, Rohit Loomba> ;Alimentary Pharmacology & Therapeutics. 2023 Feb 1
• 4 citations
  Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC.
  Suzanne R Sharpton, Rohit Loomba> ;Hepatology. 2023 Dec 1
• 11 citations
  Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease.
  Nobuharu Tamaki, Noora Ahlholm, Panu K Luukkonen, Kimmo Porthan, Suzanne R Sharpton, Veeral Ajmera, Yuko Kono, Shravan Dave, Aijaz Ahmed, Vinay Sundaram, Michael J Wil...> ;The Journal of Clinical Investigation. 2022 Nov 1
• 2 citations
  Gut metagenome-derived signature predicts hepatic decompensation and mortality in NAFLD-related cirrhosis.
  Suzanne R Sharpton, Tae Gyu Oh, Egbert Madamba, Chenjingyi Wang, Ruth T Yu, Annette R Atkins, Tao Huan, Michael Downes, Ronald M Evans, Rohit Loomba> ;Alimentary Pharmacology & Therapeutics. 2022 Nov 1
• 12 citations
  Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver Disease.
  Daniel Q Huang, Suzanne R Sharpton, Maral Amangurbanova, Nobuharu Tamaki, Claude B Sirlin, Rohit Loomba> ;Clinical Gastroenterology and Hepatology. 2023 Sep 1
• 16 citations
  Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholi...
  Veeral Ajmera, Khang Nguyen, Nobuharu Tamaki, Suzanne Sharpton, Ricki Bettencourt, Rohit Loomba> ;Therapeutic Advances in Gastroenterology. 2022 Jan 1
• 11 citations
  Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease.
  Suzanne R. Sharpton, Nobuharu Tamaki, Ricki Bettencourt, Egbert Madamba, Jinho Jung, Amy Liu, Cynthia Behling, Mark A. Valasek, Rohit Loomba> ;Therapeutic Advances in Gastroenterology. 2021 Oct 8
• 28 citations
  MRE plus FIB-4 (MEFIB) versus FAST in detection of candidates for pharmacological treatment of NASH-related fibrosis
  Nobuharu Tamaki, Kento Imajo, Suzanne R. Sharpton, Jinho Jung, Nobuyoshi Kawamura, Masato Yoneda, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi Nakajima,...> ;Hepatology. 2021 Sep 8
• 19 citations
  Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol
  Sara M. Lewin, Ryan A. McConnell, Roshan Patel, Suzanne R. Sharpton, Fernando Velayos, Uma Mahadevan> ;Inflammatory Bowel Diseases. 2019 Oct 18
• 103 citations
  Gut microbiome–targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression
  Sharpton, Maraj B, Harding-Theobald E, Eric Vittinghoff, Norah A. Terrault> ;The American Journal of Clinical Nutrition. 2019 Jul 1
• 25 citations
  Outcomes of Sleeve Gastrectomy in Obese Liver Transplant Candidates.
  Suzanne R. Sharpton, Norah A. Terrault, Andrew M. Posselt> ;Liver Transplantation. 2019 Apr 1
• 2 citations
  Prior Bariatric Surgery in Liver Transplant Candidates: Unforeseen Consequences?
  Suzanne R. Sharpton, Norah A. Terrault> ;Liver Transplantation. 2019 Feb 1
• 20 citations
  Gut Microbial Metabolism and Nonalcoholic Fatty Liver Disease.
  Suzanne R. Sharpton, Germaine J. M. Yong, Norah A. Terrault, Susan V. Lynch> ;Hepatology Communications. 2019 Jan 1
• 94 citations
  Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function
  Suzanne R. Sharpton, Veeral Ajmera, Rohit Loomba> ;Clinical Gastroenterology and Hepatology. 2019 Jan 1
• 33 citations
  Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes.
  Suzanne R. Sharpton, Sandy Feng, Bilal Hameed, Francis Y. Yao, Jennifer C. Lai> ;Transplantation. 2014 Sep 15
• 25 citations
  The Volumetric Response of Brain Metastases After Stereotactic Radiosurgery and Its Post-treatment Implications
  Suzanne R. Sharpton, Eric K. Oermann, Dominic T. Moore, Eric Schreiber, Riane Hoffman, David E. Morris, Matthew G. Ewend> ;Neurosurgery. 2014 Jan 1
• Join now to see all